{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:32:58Z","timestamp":1790641978554,"version":"4.1.0"},"reference-count":29,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["THC"],"published-print":{"date-parts":[[2023,5,12]]},"abstract":"<jats:p>BACKGROUND: Preeclampsia (PE) has adverse effects on pregnant women, fetuses, and newborns [1], and accounts for 3%\u201310% of pregnancy-related diseases globally. OBJECTIVE: This study aimed to screen a series of prenatal markers (pregnancy-associated plasma protein [PAPP-A], \u03b2-human chorionic gonadotropin [\u03b2-hCG], alpha fetoprotein [AFP], and estriol [uE3]) to establish a risk model and evaluate the diagnostic values of the markers for predicting PE. METHODS: Sixty-five pregnant women were enrolled in this study. They were divided into two groups containing healthy pregnant women (n= 51, the non-PE group) and pregnant women with PE (n= 14, the PE group). According to the stage of pregnancy, the pregnant women in each group were divided into early, middle, and late pregnancy groups for statistical analysis. The levels of PAPPA-A \u03b2-hCG, AFP, and uE3 were compared among these groups. Then, a risk model was established, and PE was diagnosed using receiver operating characteristic (ROC) curve results. RESULTS: In the early pregnancy group, the differences in the levels of PAPP-A, AFP, and uE3 between the PE and non-PE groups were statistically significant (P&lt; 0.001, P= 0.029, and P= 0.033, respectively), while the difference in the single remaining marker was not statistically significant. A ROC curve analysis revealed that in early pregnancy, the sensitivity and specificity of PAPP-A were 76.5% and 71.4%, respectively, and the sensitivity and specificity of \u03b2-hCG were 82.4% and 57.1%, respectively. The sensitivity and specificity of the combination of the two markers for diagnosing PE were 86.3% and 57.1%, respectively. CONCLUSION: This study demonstrated that the combination of PAPP-A and \u03b2-hCG has diagnostic value for PE in pregnant women. Accordingly, we should formulate innovative PE screening strategies to target the prevention of PE and create important conditions for predictive and preventive personalized medical treatments.<\/jats:p>","DOI":"10.3233\/thc-220523","type":"journal-article","created":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T11:14:00Z","timestamp":1669115640000},"page":"1027-1037","source":"Crossref","is-referenced-by-count":7,"title":["The role of serum markers PAPP-A \u03b2-hCG, AFP, and uE3 in predicting the risk of preeclampsia in early, middle, and late pregnancy"],"prefix":"10.1177","volume":"31","author":[{"given":"Weiyi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongping","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/THC-220523_ref1","unstructured":"Hypertension in pregnancy. Report of the american college of obstetricians and gynecologists\u2019 task force on hypertension in pregnancy. Obstet Gynecol. 2013; 122(5): 1122-1131."},{"issue":"3","key":"10.3233\/THC-220523_ref2","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s13224-020-01420-7","article-title":"Does the addition of serum PAPP-A and \u03b2-hCG improve the predictive value of uterine artery pulsatility index for preeclampsia at 11\u201314 weeks of gestation? A prospective observational study","volume":"71","author":"Khanam","year":"2021","journal-title":"J Obstet Gynaecol India."},{"issue":"2","key":"10.3233\/THC-220523_ref3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pathophys.2018.02.006","article-title":"Prediction of first-trimester preeclampsia: Relevance of the oxidative stress marker MDA in a combination model with PP-13, PAPP-A and beta-HCG","volume":"25","author":"Asiltas","year":"2018","journal-title":"Pathophysiology."},{"issue":"4","key":"10.3233\/THC-220523_ref4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000444524","article-title":"Early prediction of hypertensive disorders of pregnancy using cell-free fetal DNA, cell-free total DNA, and biochemical markers","volume":"40","author":"Kim","year":"2016","journal-title":"Fetal Diagn Ther."},{"issue":"5","key":"10.3233\/THC-220523_ref5","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00404-016-4111-0","article-title":"Plasma PP13 and urinary GAGs\/PGs as early markers of pre-eclampsia","volume":"294","author":"De Muro","year":"2016","journal-title":"Arch Gynecol Obstet."},{"issue":"2","key":"10.3233\/THC-220523_ref6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijgo.2015.07.021","article-title":"Early prediction of hypertension during pregnancy in a low-resource setting","volume":"132","author":"Kumar","year":"2016","journal-title":"Int J Gynaecol Obstet."},{"issue":"3","key":"10.3233\/THC-220523_ref7","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tjog.2017.01.009","article-title":"First trimester maternal serum analytes and second trimester uterine artery Doppler in the prediction of preeclampsia and fetal growth restriction","volume":"56","author":"Yu","year":"2017","journal-title":"Taiwan J Obstet Gynecol."},{"key":"10.3233\/THC-220523_ref8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejogrb.2017.08.031","article-title":"External validation of preexisting first trimester preeclampsia prediction models","volume":"217","author":"Allen","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"10.3233\/THC-220523_ref9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jri.2014.11.003","article-title":"Maternal-fetal interactions, predictive markers for preeclampsia, and programming","volume":"108","author":"Huppertz","year":"2015","journal-title":"J Reprod Immunol."},{"key":"10.3233\/THC-220523_ref10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12884-015-0608-y","article-title":"Serum screening in first trimester to predict pre-eclampsia, small for gestational age and preterm delivery: Systematic review and meta-analysis","volume":"15","author":"Zhong","year":"2015","journal-title":"BMC Pregnancy Childbirth."},{"issue":"9","key":"10.3233\/THC-220523_ref11","doi-asserted-by":"crossref","first-page":"23035","DOI":"10.3390\/ijms160923035","article-title":"Early pregnancy biomarkers in pre-eclampsia: A systematic review and meta-analysis","volume":"16","author":"Wu","year":"2015","journal-title":"Int J Mol Sci."},{"key":"10.3233\/THC-220523_ref12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/1471-0528.14004","article-title":"Applicability of first-trimester combined screening for fetal trisomy 21 in a resource-limited setting in mainland China","volume":"123","author":"Li","year":"2016","journal-title":"Bjog."},{"issue":"7","key":"10.3233\/THC-220523_ref13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/pd.4833","article-title":"The maternal age-related first trimester risks for trisomy 21, 18 and 13 based on Danish first trimester data from 2005 to 2014","volume":"36","author":"Hartwig","year":"2016","journal-title":"Prenat Diagn."},{"issue":"4","key":"10.3233\/THC-220523_ref14","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.tjog.2018.06.014","article-title":"Trisomy 21 screening based on first and second trimester in a Taiwanese population","volume":"57","author":"Lan","year":"2018","journal-title":"Taiwan J Obstet Gynecol."},{"issue":"6","key":"10.3233\/THC-220523_ref15","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/uog.15849","article-title":"Maternal serum PAPP-A and free \u03b2-hCG at 12, 22 and 32 weeks\u2019 gestation in screening for pre-eclampsia","volume":"47","author":"Wright","year":"2016","journal-title":"Ultrasound Obstet Gynecol."},{"issue":"11","key":"10.3233\/THC-220523_ref16","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1210\/jc.2002-020642","article-title":"Characterization of human chorionic gonadotropin as a novel angiogenic factor","volume":"87","author":"Zygmunt","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"key":"10.3233\/THC-220523_ref17","first-page":"8264958","article-title":"Predicting hypertensive disease in the first trimester of pregnancy: Risk models and analysis of serum d-dimer levels combined with plasma pregnancy-associated protein a, free \u03b2-subunit of human chorionic gonadotropin, and fetal nuchal translucency","volume":"2022","author":"Chen","year":"2022","journal-title":"Biomed Res Int."},{"issue":"4","key":"10.3233\/THC-220523_ref18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/uog.20224","article-title":"Delivery or expectant management for prevention of adverse maternal and neonatal outcomes in hypertensive disorders of pregnancy: An individual participant data meta-analysis","volume":"53","author":"Bernardes","year":"2019","journal-title":"Ultrasound Obstet Gynecol."},{"issue":"1","key":"10.3233\/THC-220523_ref19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.prp.2017.10.021","article-title":"Angiogenic and antiangiogenic factors in preeclampsia","volume":"214","author":"Helmo","year":"2018","journal-title":"Pathol Res Pract."},{"issue":"2","key":"10.3233\/THC-220523_ref20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.kjms.2017.10.001","article-title":"An analysis of the risk factors of preeclampsia and prediction based on combined biochemical indexes","volume":"34","author":"Quan","year":"2018","journal-title":"Kaohsiung J Med Sci."},{"issue":"1","key":"10.3233\/THC-220523_ref21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12884-022-04514-4","article-title":"Modified multiple marker aneuploidy screening as a primary screening test for preeclampsia","volume":"22","author":"Huang","year":"2022","journal-title":"BMC Pregnancy Childbirth."},{"issue":"1","key":"10.3233\/THC-220523_ref22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s13224-017-0988-1","article-title":"First-trimester inflammatory markers for risk evaluation of pregnancy hypertension","volume":"68","author":"Sharma","year":"2018","journal-title":"J Obstet Gynaecol India."},{"issue":"10","key":"10.3233\/THC-220523_ref23","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1471-0528.2000.tb11618.x","article-title":"First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications","volume":"107","author":"Ong","year":"2000","journal-title":"Bjog."},{"issue":"4","key":"10.3233\/THC-220523_ref24","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1210\/jcem.87.4.8430","article-title":"Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth","volume":"87","author":"Smith","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"10.3233\/THC-220523_ref25","first-page":"194","article-title":"Pregnancy-associated plasma protein A (PAPP-A): Theoretical and clinical aspects","volume":"103","author":"Fialova","year":"2002","journal-title":"Bratisl Lek Listy."},{"issue":"3","key":"10.3233\/THC-220523_ref26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s13167-020-00212-3","article-title":"A risk model of prenatal screening markers in first trimester for predicting hypertensive disorders of pregnancy","volume":"11","author":"Chen","year":"2020","journal-title":"Epma J."},{"key":"10.3233\/THC-220523_ref27","doi-asserted-by":"crossref","first-page":"324","DOI":"10.4103\/wjtcm.wjtcm_34_20","article-title":"Analysis of phytochemical constituents of zuogui wan in rat serum and its effects on early embryonic development of mice","volume":"6","author":"Guo","year":"2020","journal-title":"World J Tradit Chin Med."},{"key":"10.3233\/THC-220523_ref28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4137\/CMRH.S21865","article-title":"Combination of PAPPA, fhCG\u03b2, AFP, PlGF, sTNFR1, and maternal characteristics in prediction of early-onset preeclampsia","volume":"9","author":"Yliniemi","year":"2015","journal-title":"Clin Med Insights Reprod Health."},{"issue":"3","key":"10.3233\/THC-220523_ref29","first-page":"568","article-title":"The role of maternal serumbeta-HCG and PAPP-A levels at gestational weeks 10 to 14 in the prediction of pre-eclampsia","volume":"30","author":"Ozdamar","year":"2014","journal-title":"Pak J Med Sci."}],"container-title":["Technology and Health Care"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/THC-220523","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:55:46Z","timestamp":1777614946000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/THC-220523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,12]]},"references-count":29,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/thc-220523","relation":{},"ISSN":["0928-7329","1878-7401"],"issn-type":[{"value":"0928-7329","type":"print"},{"value":"1878-7401","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,12]]}}}